Helen Collins
Chief Tech/Sci/R&D Officer at ENLIVEN THERAPEUTICS, INC.
Net worth: - $ as of 2024-03-30
Network origin in Helen Collins first degree
Entity | Entity type | Industry | |
---|---|---|---|
Subsidiary | Biotechnology | 27 | |
Public Company | Biotechnology | 17 | |
Public Company | Biotechnology | 15 | |
Public Company | Biotechnology | 13 | |
Bryn Mawr College
11
| College/University | Other Consumer Services | 11 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Helen Collins via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Consultant / Advisor Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Treasurer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
INTEL CORPORATION | Semiconductors | Corporate Officer/Principal Corporate Secretary | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member | |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Miscellaneous Commercial Services | Founder President | |
RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Afferent Pharmaceuticals, Inc. develops selective drugs for the treatment of debilitating neurogenic disorders. It offers programs for respiratory, cardiovascular, chronic pain, biology, and clinical trials. The firm offers drugs for osteoarthritis pain, treatment-refractory chronic cough, and interstitial cystitis or bladder pain syndrome. The company was founded by Anthony P. Ford in December 2009 and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
TURG POIN | Pharmaceuticals: Major | Chairman Chairman | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin Graduate Degree | |
University of Oxford | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
MIRATI THERAPEUTICS | Biotechnology | Chairman Director/Board Member | |
The University of Texas at Austin | College/University | Graduate Degree Corporate Officer/Principal | |
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
The University of Colorado | College/University | Corporate Officer/Principal Masters Business Admin | |
University of Michigan | College/University | Masters Business Admin Undergraduate Degree Masters Business Admin Doctorate Degree | |
The University of California, San Francisco | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
AMBRX INC | Pharmaceuticals: Major | Director/Board Member Founder | |
University of Copenhagen | College/University | Doctorate Degree Doctorate Degree Corporate Officer/Principal | |
PDL BIOPHARMA, INC. | Biotechnology | Chief Executive Officer General Counsel Chief Executive Officer Human Resources Officer | |
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
US Pharmaceuticals, Inc.
US Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology US Pharmaceuticals, Inc. manufactures and distributes medicines. The private company is based in Seal Beach, CA. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
TriSalus Operating Life Sciences, Inc.
TriSalus Operating Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology TriSalus Operating Life Sciences, Inc. develops infusion systems for the interventional radiology and oncology markets. Its infusion systems are designed to deliver embolic agents through a micro-catheter with an expandable tip that collapses in forward flow and expands the vessel wall in reverse flow to increase targeted delivery, minimize reflux, and reduce damage to healthy tissue. The company was founded by Aravind Arepally and James E. Chomas in 2011 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
DERMIRA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Founder | |
ALECTOR, INC. | Biotechnology | Director of Finance/CFO Director of Finance/CFO | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Kellogg School of Management | College/University | Masters Business Admin Masters Business Admin | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
Enliven Therapeutics, Inc. /US/
Enliven Therapeutics, Inc. /US/ BiotechnologyHealth Technology EnLiven Therapeutics, Inc. engages in the discovery and development of small molecule treatments for cancer. The company was founded by Samuel S. Kintz and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Founder Founder Director/Board Member | |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chairman Director/Board Member Director/Board Member Chief Executive Officer | |
Qiming US Ventures Management, LLC
Qiming US Ventures Management, LLC Investment ManagersFinance Qiming US Ventures Management LLC (Qiming Venture Partners) is a Venture Capital subsidiary of Qiming Venture Partners Ltd founded in 2017 by Mark D. McDade and Gary Edward Rieschel. The firm is headquartered in Cambridge, Massachusetts. | Investment Managers | Consultant / Advisor Founder Consultant / Advisor | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Biotechnology | Chairman Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Escient Pharmaceuticals, Inc.
Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Escient Pharmaceuticals, Inc. operates as a bio-technology company. It develops in-class G Protein-Coupled Receptor targeted drugs to address serious, unserved medical needs. The company was founded by Alain D. Baron, Marcus F. Boehm and Xinzhong Dong and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
ALIGOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
PMV PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
APEXIGEN, INC. | Biotechnology | Director of Finance/CFO President | |
RAYZEBIO, INC. | Biotechnology | Chairman Chief Executive Officer |
Statistics
International
United States | 47 |
United Kingdom | 3 |
Denmark | 3 |
Sectoral
Health Technology | 35 |
Consumer Services | 12 |
Commercial Services | 3 |
Electronic Technology | 2 |
Miscellaneous | 2 |
Operational
Director/Board Member | 492 |
Corporate Officer/Principal | 196 |
Independent Dir/Board Member | 184 |
Chairman | 69 |
Undergraduate Degree | 66 |
Most connected contacts
Insiders | |
---|---|
Fred Cohen | 58 |
Andrew Schwab | 45 |
Franklin Berger | 41 |
Kapil Dhingra | 39 |
Jack Nielsen | 38 |
Mark McDade | 35 |
Richard Heyman | 33 |
William Ringo | 32 |
Rishi Gupta | 29 |
Faheem Hasnain | 27 |
Jake Bauer | 24 |
Andrew Phillips | 23 |
Lewis Williams | 23 |
Robert Hoffman | 22 |
Peter Frank Drake | 22 |
- Stock Market
- Insiders
- Helen Collins
- Company connections